100 related articles for article (PubMed ID: 20665623)
1. How adhesion/growth-regulatory galectins-1 and -3 attain cell specificity: case study defining their target on neuroblastoma cells (SK-N-MC) and marked affinity regulation by affecting microdomain organization of the membrane.
Kopitz J; Bergmann M; Gabius HJ
IUBMB Life; 2010 Aug; 62(8):624-8. PubMed ID: 20665623
[TBL] [Abstract][Full Text] [Related]
2. Determination of structural and functional overlap/divergence of five proto-type galectins by analysis of the growth-regulatory interaction with ganglioside GM1 in silico and in vitro on human neuroblastoma cells.
André S; Kaltner H; Lensch M; Russwurm R; Siebert HC; Fallsehr C; Tajkhorshid E; Heck AJ; von Knebel Doeberitz M; Gabius HJ; Kopitz J
Int J Cancer; 2005 Mar; 114(1):46-57. PubMed ID: 15523676
[TBL] [Abstract][Full Text] [Related]
3. Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.
Rapoport EM; André S; Kurmyshkina OV; Pochechueva TV; Severov VV; Pazynina GV; Gabius HJ; Bovin NV
Glycobiology; 2008 Apr; 18(4):315-24. PubMed ID: 18256179
[TBL] [Abstract][Full Text] [Related]
4. Galectin-1 is a major receptor for ganglioside GM1, a product of the growth-controlling activity of a cell surface ganglioside sialidase, on human neuroblastoma cells in culture.
Kopitz J; von Reitzenstein C; Burchert M; Cantz M; Gabius HJ
J Biol Chem; 1998 May; 273(18):11205-11. PubMed ID: 9556610
[TBL] [Abstract][Full Text] [Related]
5. Beyond glycoproteins as galectin counterreceptors: tumor-effector T cell growth control via ganglioside GM1 [corrected].
Ledeen RW; Wu G; André S; Bleich D; Huet G; Kaltner H; Kopitz J; Gabius HJ
Ann N Y Acad Sci; 2012 Apr; 1253():206-21. PubMed ID: 22524425
[TBL] [Abstract][Full Text] [Related]
6. Ganglioside GM1/galectin-dependent growth regulation in human neuroblastoma cells: special properties of bivalent galectin-4 and significance of linker length for ligand selection.
Kopitz J; Ballikaya S; André S; Gabius HJ
Neurochem Res; 2012 Jun; 37(6):1267-76. PubMed ID: 22234579
[TBL] [Abstract][Full Text] [Related]
7. Specific binding of amyloid-beta-protein to IMR-32 neuroblastoma cell membrane.
Inaba S; Okada T; Konakahara T; Kodaka M
J Pept Res; 2005 May; 65(5):485-90. PubMed ID: 15853942
[TBL] [Abstract][Full Text] [Related]
8. Redistribution of P-selectin glycoprotein ligand-1 (PSGL-1) in chemokine-treated neutrophils: a role of lipid microdomains.
Itoh S; Susuki C; Takeshita K; Nagata K; Tsuji T
J Leukoc Biol; 2007 Jun; 81(6):1414-21. PubMed ID: 17372146
[TBL] [Abstract][Full Text] [Related]
9. D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol alters cellular cholesterol homeostasis by modulating the endosome lipid domains.
Makino A; Ishii K; Murate M; Hayakawa T; Suzuki Y; Suzuki M; Ito K; Fujisawa T; Matsuo H; Ishitsuka R; Kobayashi T
Biochemistry; 2006 Apr; 45(14):4530-41. PubMed ID: 16584188
[TBL] [Abstract][Full Text] [Related]
10. On the mechanism of internalization of alpha-synuclein into microglia: roles of ganglioside GM1 and lipid raft.
Park JY; Kim KS; Lee SB; Ryu JS; Chung KC; Choo YK; Jou I; Kim J; Park SM
J Neurochem; 2009 Jul; 110(1):400-11. PubMed ID: 19457104
[TBL] [Abstract][Full Text] [Related]
11. Glycolipid depletion using a ceramide analogue (PDMP) alters growth, adhesion, and membrane lipid organization in human A431 cells.
Barbour S; Edidin M; Felding-Habermann B; Taylor-Norton J; Radin NS; Fenderson BA
J Cell Physiol; 1992 Mar; 150(3):610-9. PubMed ID: 1537889
[TBL] [Abstract][Full Text] [Related]
12. Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells.
Kopitz J; André S; von Reitzenstein C; Versluis K; Kaltner H; Pieters RJ; Wasano K; Kuwabara I; Liu FT; Cantz M; Heck AJ; Gabius HJ
Oncogene; 2003 Sep; 22(40):6277-88. PubMed ID: 13679866
[TBL] [Abstract][Full Text] [Related]
13. Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer.
Moiseeva EV; Rapoport EM; Bovin NV; Miroshnikov AI; Chaadaeva AV; Krasilshschikova MS; Bojenko VK; Bijleveld C; van Dijk JE; Den Otter W
Breast Cancer Res Treat; 2005 Jun; 91(3):227-41. PubMed ID: 15952056
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol-rich plasma membrane domains (lipid rafts) in keratinocytes: importance in the baseline and UVA-induced generation of reactive oxygen species.
Gniadecki R; Christoffersen N; Wulf HC
J Invest Dermatol; 2002 Apr; 118(4):582-8. PubMed ID: 11918702
[TBL] [Abstract][Full Text] [Related]
15. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
Ohannesian DW; Lotan D; Lotan R
Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433
[TBL] [Abstract][Full Text] [Related]
16. Abrogation of shedding of immunosuppressive neuroblastoma gangliosides.
Li R; Ladisch S
Cancer Res; 1996 Oct; 56(20):4602-5. PubMed ID: 8840970
[TBL] [Abstract][Full Text] [Related]
17. Fas signaling induces raft coalescence that is blocked by cholesterol depletion in human RPE cells undergoing apoptosis.
Lincoln JE; Boling M; Parikh AN; Yeh Y; Gilchrist DG; Morse LS
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2172-8. PubMed ID: 16639029
[TBL] [Abstract][Full Text] [Related]
18. Effects of cell surface ganglioside sialidase inhibition on growth control and differentiation of human neuroblastoma cells.
Kopitz J; Mühl C; Ehemann V; Lehmann C; Cantz M
Eur J Cell Biol; 1997 May; 73(1):1-9. PubMed ID: 9174666
[TBL] [Abstract][Full Text] [Related]
19. Unique conformer selection of human growth-regulatory lectin galectin-1 for ganglioside GM1 versus bacterial toxins.
Siebert HC; André S; Lu SY; Frank M; Kaltner H; van Kuik JA; Korchagina EY; Bovin N; Tajkhorshid E; Kaptein R; Vliegenthart JF; von der Lieth CW; Jiménez-Barbero J; Kopitz J; Gabius HJ
Biochemistry; 2003 Dec; 42(50):14762-73. PubMed ID: 14674750
[TBL] [Abstract][Full Text] [Related]
20. Effects of D-threo-PDMP, an inhibitor of glucosylceramide synthetase, on expression of cell surface glycolipid antigen and binding to adhesive proteins by B16 melanoma cells.
Inokuchi J; Momosaki K; Shimeno H; Nagamatsu A; Radin NS
J Cell Physiol; 1989 Dec; 141(3):573-83. PubMed ID: 2531751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
